Search This Blog

Thursday, November 7, 2019

Lexicon Pharmaceuticals EPS beats by $1.41, beats on revenue

Lexicon Pharmaceuticals (NASDAQ:LXRX): Q3 GAAP EPS of $1.95 beats by $1.41.
Revenue of $294.4M (+4105.7% Y/Y) beats by $282.4M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)